Everstone Capital invests Rs 220 crore in Rubicon Research - Feedback

Everstone Capital has invested Rs 220 crore in contract research and drug delivery company Rubicon Research, the latest investment by the mid-market private equity firm, as it steps up its deal making pace, and continues to diversify its portfolio.

The $33 million investment, which has both, primary and secondary components, will also provide Kotak Private Equity, an early investor in Mumbai-based Rubicon Research, a full exit from the company, having invested Rs 60 crore till date. Post this transaction, Everstone will own a 70% stake in Rubicon. “Rubicon has an excellent record of providing cutting-edge solutions to the healthcare and pharmaceutical industry. We are excited about enhancing its capabilities,” said Sameer Sain, managing partner of the Everstone Group.

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/everstone-capital-invests-rs-220-crore-in-rubicon-research/articleshow/55027696.cms

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *